Shu‐Chi Wang

2.7k total citations
87 papers, 1.9k citations indexed

About

Shu‐Chi Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shu‐Chi Wang has authored 87 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 21 papers in Cancer Research and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shu‐Chi Wang's work include Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (11 papers) and Immune cells in cancer (9 papers). Shu‐Chi Wang is often cited by papers focused on Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (11 papers) and Immune cells in cancer (9 papers). Shu‐Chi Wang collaborates with scholars based in Taiwan, United States and Japan. Shu‐Chi Wang's co-authors include Chi‐Shiun Chiang, Ji‐Hong Hong, Chia‐Yang Li, Wei‐Chung Cheng, Po‐Len Liu, Ching‐Fang Yu, George T.Y. Chen, Chuen Hsueh, Shih‐Hua Fang and Yevgeniy Lukyanov and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shu‐Chi Wang

86 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Chi Wang Taiwan 23 847 520 436 367 250 87 1.9k
Yuanyuan Zhang China 28 927 1.1× 418 0.8× 249 0.6× 342 0.9× 142 0.6× 102 2.4k
Oluwaseun Adebayo Bamodu Taiwan 28 1.1k 1.3× 196 0.4× 569 1.3× 468 1.3× 208 0.8× 67 2.0k
Ji Zhang China 26 1.5k 1.8× 256 0.5× 654 1.5× 358 1.0× 286 1.1× 112 2.5k
Lan Wang China 25 905 1.1× 367 0.7× 338 0.8× 274 0.7× 148 0.6× 74 1.8k
Yung‐Luen Yu Taiwan 28 1.7k 2.0× 272 0.5× 701 1.6× 592 1.6× 576 2.3× 80 2.6k
Wen Peng China 24 1.5k 1.8× 262 0.5× 566 1.3× 732 2.0× 262 1.0× 60 2.8k
Yuan Qin China 26 1.2k 1.5× 258 0.5× 595 1.4× 420 1.1× 197 0.8× 120 2.2k

Countries citing papers authored by Shu‐Chi Wang

Since Specialization
Citations

This map shows the geographic impact of Shu‐Chi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Chi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Chi Wang more than expected).

Fields of papers citing papers by Shu‐Chi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Chi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Chi Wang. The network helps show where Shu‐Chi Wang may publish in the future.

Co-authorship network of co-authors of Shu‐Chi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Chi Wang. A scholar is included among the top collaborators of Shu‐Chi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Chi Wang. Shu‐Chi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Meng‐Hsuan, Zi-Jing Lin, Chih‐Hsin Hsu, et al.. (2025). Magnolol facilitates mitochondrial-peroxisome dysfunction and induces oxeiptosis in lung cancer cells following transfer via tunneling nanotubes. Biomedicine & Pharmacotherapy. 187. 118126–118126. 6 indexed citations
2.
Wang, Shu‐Chi, et al.. (2024). Abstract 7443: Investigating the impact of ferroptosis in a high-fat and high-oxidative stress hepatic steatosis environment. Cancer Research. 84(6_Supplement). 7443–7443. 1 indexed citations
3.
Chang, Kun‐Che, Po‐Yen Lee, Po‐Len Liu, et al.. (2023). Nordalbergin Exerts Anti-Neuroinflammatory Effects by Attenuating MAPK Signaling Pathway, NLRP3 Inflammasome Activation and ROS Production in LPS-Stimulated BV2 Microglia. International Journal of Molecular Sciences. 24(8). 7300–7300. 12 indexed citations
4.
Lee, Po‐Yen, I‐Chen Chen, Po‐Len Liu, et al.. (2023). Kurarinone exerts anti-inflammatory effect via reducing ROS production, suppressing NLRP3 inflammasome, and protecting against LPS-induced sepsis. Biomedicine & Pharmacotherapy. 167. 115619–115619. 14 indexed citations
5.
Yang, Chi‐Rei, Yen‐Chuan Ou, Chen‐Li Cheng, et al.. (2023). Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer. Oncology Letters. 26(1). 284–284. 2 indexed citations
6.
Liu, Chia-Hsin, Shu‐Chi Wang, Shu‐Pin Huang, et al.. (2022). Identification of a Steroid Hormone-Associated Gene Signature Predicting the Prognosis of Prostate Cancer through an Integrative Bioinformatics Analysis. Cancers. 14(6). 1565–1565. 3 indexed citations
7.
Lee, Po‐Yen, Po‐Len Liu, Pei‐Chang Wu, et al.. (2022). Punicalagin Attenuates LPS-Induced Inflammation and ROS Production in Microglia by Inhibiting the MAPK/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation. Journal of Inflammation Research. Volume 15. 5347–5359. 28 indexed citations
8.
Lai, Yu‐Hung, Wei‐Lun Liu, Tsung‐Ying Lee, et al.. (2022). Magnolol regulates miR-200c-3p to inhibit epithelial–mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo. Phytomedicine. 110. 154597–154597. 5 indexed citations
9.
Yeh, Hsin‐Chih, Chia‐Cheng Su, Bo‐Ying Bao, et al.. (2022). Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer. European Journal of Pharmacology. 923. 174929–174929. 2 indexed citations
10.
Teng, Pai‐Chi, Shu‐Pin Huang, Chia-Hsin Liu, et al.. (2021). Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis. International Journal of Molecular Sciences. 22(21). 11771–11771. 8 indexed citations
11.
Jang, Tyng‐Yuan, Chung‐Feng Huang, Chia‐Yen Dai, et al.. (2021). The Prevalence and Serological Association of Hepatitis D Virus Genotypes in Taiwan. Pathogens. 10(10). 1227–1227. 1 indexed citations
12.
Wang, Shu‐Chi, I‐Chen Chen, Yi‐Ting Chen, et al.. (2021). Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation. Pharmaceuticals. 14(6). 588–588. 27 indexed citations
13.
Li, Chia‐Yang, Wei‐Chung Cheng, Chung‐Feng Huang, et al.. (2021). The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 Expression. Biomedicines. 9(10). 1446–1446. 4 indexed citations
14.
Hsu, Kai‐Wen, Yu‐Feng Lin, George T.Y. Chen, et al.. (2021). Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma. Molecular Therapy — Nucleic Acids. 25. 1–10. 10 indexed citations
15.
Yeh, Ming‐Lun, Pei‐Chien Tsai, Shu‐Chi Wang, et al.. (2021). Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR. Cancers. 13(14). 3455–3455. 12 indexed citations
16.
Lee, Po‐Yen, Shu‐Chi Wang, Po‐Len Liu, et al.. (2021). Mycotoxin Zearalenone Attenuates Innate Immune Responses and Suppresses NLRP3 Inflammasome Activation in LPS-Activated Macrophages. Toxins. 13(9). 593–593. 17 indexed citations
17.
Wang, Shu‐Chi, Chia‐Yang Li, Wen‐Tsan Chang, et al.. (2020). Exosome‐derived differentiation antagonizing non‐protein coding RNA with risk of hepatitis C virus‐related hepatocellular carcinoma recurrence. Liver International. 41(5). 956–968. 22 indexed citations
18.
Wang, Shu‐Chi, et al.. (2017). Ectopic Thyroid Tissue in the Adrenal Gland Mimicking a Pheochromocytoma. Journal of Endourology Case Reports. 3(1). 149–151. 7 indexed citations
19.
Lee, Te‐Wei, et al.. (2011). Imaging, Autoradiography, and Biodistribution of 188 Re-Labeled PEGylated Nanoliposome in Orthotopic Glioma Bearing Rat Model. Cancer Biotherapy and Radiopharmaceuticals. 26(6). 717–725. 22 indexed citations
20.
Li, Chia‐Yang, Louis Kuoping Chao, Shu‐Chi Wang, et al.. (2010). Honokiol inhibits LPS‐induced maturation and inflammatory response of human monocyte‐derived dendritic cells. Journal of Cellular Physiology. 226(9). 2338–2349. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanyuan Zhang Breakdown of academic impact, for papers by Oluwaseun Adebayo Bamodu Breakdown of academic impact, for papers by Ji Zhang Breakdown of academic impact, for papers by Lan Wang Breakdown of academic impact, for papers by Yung‐Luen Yu Breakdown of academic impact, for papers by Wen Peng Breakdown of academic impact, for papers by Yuan Qin
Rankless by CCL
2026